News &amp; Updates

Granisetron on par with palonosetron in preventing emesis in NSCLC patients

20 Dec 2025 by

Both granisetron and palonosetron are comparable in the prevention of acute and delayed emesis in patients with nonsmall cell lung cancer (NSCLC) receiving cisplatin based high emetogenic chemotherapy (HEC), a study has shown.

Granisetron on par with palonosetron in preventing emesis in NSCLC patients

Real-time CGM use reduces odds of LGA births in pregnant women with gestational diabetes

In pregnancies complicated by gestational diabetes, the use of continuous glucose monitoring in real time appears to reduce the likelihood of delivering large-for-gestational-age newborns, as shown in a study.

Real-time CGM use reduces odds of LGA births in pregnant women with gestational diabetes

$Botulinum toxin shots a promising treatment for refractory digital ischaemia$

Botulinum toxin shots a promising treatment for refractory digital ischaemia

Botulinum toxin injections appear to be a safe and efficacious adjunct in the treatment of refractory digital ischaemia in patients with systemic sclerosis, according to a systematic review and individual participant data meta-analysis.

Botulinum toxin shots a promising treatment for refractory digital ischaemia

Haptic wearable may dial down nocturnal scratching in mild eczema

A hand-mounted wearable sensor that delivers closed-loop haptic feedback has the potential helps reduce nocturnal scratching in patients with mild atopic dermatitis (AD), as shown in a small study.

Haptic wearable may dial down nocturnal scratching in mild eczema

Corticosteroids, IVIG help reduce risk of aneurysm in children with MIS-C

The use of corticosteroids, intravenous immunoglobulin (IVIG), and their combination appear to protect children with multisystem inflammatory syndrome (MIS-C) against aneurysm compared with no immunomodulatory treatment, suggests a study.

Corticosteroids, IVIG help reduce risk of aneurysm in children with MIS-C

Which factors predicting ARI-related readmission to ED?

In the postpandemic period, readmissions to the emergency department (ED) for paediatric acute respiratory infections (ARI) appear to be driven by several factors, suggests a study.

Which factors predicting ARI-related readmission to ED?

Once-daily osilodrostat restore cortisol rhythm in patients with Cushing syndrome

Treatment with osilodrostat once daily is safe and effective in patients with biochemically controlled Cushing syndrome (CS), improving circadian cortisol rhythm, a study has shown.

Once-daily osilodrostat restore cortisol rhythm in patients with Cushing syndrome

VAYHIT2 shows disease-modifying potential of ianalumab for ITP

The primary analysis of the phase III VAYHIT2 trial shows the treatment potential of ianalumab when combined with standard-of-care eltrombopag in individuals with primary immune thrombocytopenia (ITP) requiring second-line (2L) treatment after failure of first-line (1L) corticosteroids.

VAYHIT2 shows disease-modifying potential of ianalumab for ITP